OMX Copenhagen PI
1.331,50
PKT
-3,27
PKT
-0,25
%
Werbung
Analysen zu OMX Copenhagen PI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
01.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
27.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
27.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
18.11.24 | Novo Nordisk Neutral | UBS AG | |
15.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
14.11.24 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
13.11.24 | Novo Nordisk Neutral | UBS AG | |
11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
11.11.24 | Novo Nordisk Neutral | UBS AG | |
11.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
08.11.24 | Novo Nordisk Overweight | Barclays Capital | |
07.11.24 | Novo Nordisk Neutral | UBS AG | |
07.11.24 | Novo Nordisk Halten | DZ BANK | |
07.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
07.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.11.24 | Novo Nordisk Neutral | UBS AG | |
06.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
06.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.11.24 | Novo Nordisk Neutral | UBS AG | |
06.11.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
04.11.24 | Novo Nordisk Neutral | UBS AG | |
04.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
04.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
01.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
31.10.24 | Novo Nordisk Buy | Deutsche Bank AG | |
31.10.24 | A.P. Moeller - Maersk A-S (B) Neutral | UBS AG | |
30.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
28.10.24 | Novo Nordisk Neutral | UBS AG | |
22.10.24 | Novo Nordisk Halten | DZ BANK | |
21.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
21.10.24 | Novo Nordisk Underperform | Bernstein Research | |
17.10.24 | A.P. Moeller - Maersk A-S (B) Neutral | UBS AG | |
15.10.24 | Novo Nordisk Neutral | UBS AG | |
10.10.24 | Novo Nordisk Buy | Deutsche Bank AG | |
03.10.24 | Novo Nordisk Neutral | UBS AG | |
27.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
23.09.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
20.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
20.09.24 | Novo Nordisk Underperform | Jefferies & Company Inc. |